Human leukocyte antigen system associations in Malassezia-related skin diseases

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Background: The human leukocyte antigen system (HLA) is divided into two classes involved in antigen presentation: class I presenting intracellular antigens and class II presenting extracellular antigens. While susceptibility to infections is correlated with the HLA system, data on associations between HLA genotypes and Malassezia-related skin diseases (MRSD) are lacking. Thus, the objective of this study was to investigate associations between HLA alleles and MRSD. Materials and methods: Participants in The Danish Blood Donor Study (2010–2018) provided questionnaire data on life style, anthropometric measures, and registry data on filled prescriptions. Genotyping was done using Illumina Infinium Global Screening Array, and HLA alleles were imputed using the HIBAG algorithm. Cases and controls were defined using filled prescriptions on topical ketoconazole 2% as a proxy of MRSD. Logistic regressions assessed associations between HLA alleles and MRSD adjusted for confounders and Bonferroni corrected for multiple tests. Results: A total of 9455 participants were considered MRSD cases and 24,144 participants as controls. We identified four risk alleles B*57:01, OR 1.19 (95% CI: 1.09–1.31), C*01:02, OR 1.19 (95% CI: 1.08–1.32), C*06:02, OR 1.14 (95% CI: 1.08–1.22), and DRB1*01:01, OR 1.10 (95% CI: 1.04–1.17), and two protective alleles, DQB1*02:01, OR 0.89 (95% CI: 0.85–0.94), and DRB1*03:01, OR 0.89 (95% CI: 0.85–0.94). Conclusion: Five novel associations between HLA alleles and MRSD were identified in our cohort, and one previous association was confirmed. Future studies should assess the correlation between Malassezia antigens and antigen-binding properties of the associated HLA alleles.

OriginalsprogEngelsk
TidsskriftArchives of Dermatological Research
Vol/bind315
Sider (fra-til)895–902
Antal sider8
ISSN0340-3696
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
The Danish Blood Donor Study is funded by: The Danish Council for Independent Research—Medical Sciences (grant number: 09–069412); The Danish Administrative Regions ( http://www.regioner.dk ); The A.P. Møller Foundation for the Advancement of Medical Science; The Danish Bio- and Genome Bank ( http://www.regioner.dk/rbgben ). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript.

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

ID: 327944539